Stage II Squamous Cell Carcinoma of the Head and Neck
1 clinical trials · Condition
◉ Watch Stage II Squamous Cell Carcinoma of the Head and Neck
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma (NCT06161545) | National Cancer Institute (NCI) | 2025-09-24 |
Track Stage II Squamous Cell Carcinoma of the Head and Neck automatically
Every clearance here is in the API, with alerts when new ones post.